![]() |
|||
|
|
|||
|
In the 1970's, scientists at Brookhaven National
Laboratory, the University of
Pennsylvania and the National Institutes of Health, combined chemistry, neuroscience and
instrumentation to develop 18FDG , a radiotracer for imaging brain
function in the living human being. This revolutionized the study
of the human brain.
18FDG/PET images showing brain function in a normal subject and in a cocaine addict. The cocaine addict has depressed metabolism in frontal regions when compared to the normal subject. Low frontal metabolism may underlie the loss of control in cocaine addiction. PET Addiction Studies | PET home Original LiteratureBM
Gallagher, A ansari, H Atkins, V Casella, DR Christman, JS Fowler, T Ido,
RR MacGregor, P Som, C-N Wan, AP Wolf, DE Kuhl, M Reivich. Radiopharmaceuticals
XXVII: 18F-labeled
2-deoxy-2-fluoro-D-glucose as a radiopharmaceutical for measuring
regional myocardial glucose metabolism in vivo: tissue distribution and
imaging studies in animals. J Nucl Med 18: 990-996, 1977. T Ido, C-N Wan, V Casella,
JS Fowler, AP Wolf, M Reivich and D Kuhl. Labeled 2-deoxy-D-glucose
analogs. F-18 labeled 2-deoxy-2-fluoro-D-glucose,
2-deoxy-2-fluoro-D-mannose and C-14 2-deoxy-2-fluoro-D-glucose. J
Labeled Compounds and Radiopharm. 14: 175-184, 1978. M Reivich, D Kuhl, AP Wolf,
J Greenberg, M Phelps, T Ido, V Casella, J Fowler, E Hoffman, A Alavi, P
Som and L Sokoloff. The 18F-fluorodeoxyglucose method for the
measurement of local cerebral glucose utilization in man. Circ.
Research 44, 127-137 (1979). P Som, HL Atkins, D
Bandoypadhyay, JS.Fowler, RR MacGregor, KÊMatsui, ZH Oster, DF Sacker,
CY Shiue, H Turner, C-N Wan, A P Wolf and S Zabinski. A fluorinated
glucose analog, 2-fluoro-2-deoxy-D-glucose (18F): Nontoxic tracer for
rapid tumor detection. J Nucl Med 21, 670-675 (1980). ND Volkow, R Hitzemann, G-J Wang, JS Fowler, AP Wolf, and SL Dewey. Long-term frontal brain metabolic changes in cocaine abusers. Synapse 11, 184-190 (1992). |
|
||
|
|
|||
Last updated July 23, 2004 . |
|||